# SIGLECL1

## Overview
SIGLECL1 is a gene that encodes a protein belonging to the sialic acid-binding immunoglobulin-type lectins (Siglecs) family, which are known for their roles in immune cell interactions and signaling. The protein encoded by SIGLECL1, often referred to as Siglec-like 1, is part of the immunoglobulin superfamily and is characterized by its immunoglobulin-like domains that typically facilitate binding to sialic acid residues on glycoproteins and glycolipids (Crocker2004CD33Related). However, in humans, this protein has lost its sialic acid-binding ability, a function that is retained in other primates (Crocker2004CD33Related). Despite this loss, SIGLECL1 continues to play a significant role in the modulation of immune responses, primarily through its expression in immune cells (Crocker2004CD33Related). The gene is located on chromosome 19q, within a cluster of CD33-related siglec genes, indicating a shared evolutionary history and potential functional similarities (Crocker2004CD33Related).

## Structure
The SIGLECL1 gene encodes a protein that is part of the sialic acid-binding immunoglobulin-type lectins (Siglecs) family. The protein structure typically includes immunoglobulin-like domains, which are characteristic of Siglecs and facilitate binding to sialic acid residues on glycoproteins and glycolipids (Crocker2004CD33Related). The SIGLECL1 protein is noted for having lost its sialic acid-binding ability in humans, although it retains this function in primates (Crocker2004CD33Related). 

The genomic organization of SIGLECL1 includes a signal peptide and one V-set immunoglobulin domain, followed by a variable number of C2-set immunoglobulin domains. The long form of the SiglecL1 gene, which is another name for SIGLECL1, contains an extra V-set domain (Yousef2002Genomic). The transmembrane domain is encoded by a separate exon, and the cytoplasmic domain is encoded by two exons containing ITIM and ITIM-like motifs, which are involved in signaling (Yousef2002Genomic). 

Post-translational modifications such as glycosylation may occur, influencing the protein's function and stability. Variants in splicing can lead to different isoforms, potentially altering the protein's structural and functional properties (Crocker2004CD33Related).

## Function
SIGLECL1, a member of the sialic acid-binding immunoglobulin-type lectins (Siglecs), is involved in cell-cell interactions and modulation of immune responses. In humans, SIGLECL1 has lost its ability to bind sialic acids, a function retained in primates, but it still plays a role in immune system regulation (Crocker2004CD33Related). The protein encoded by SIGLECL1 is part of the immunoglobulin superfamily and is primarily expressed in immune cells, where it contributes to cellular communication and potentially impacts immune system regulation and pathogen recognition (Crocker2004CD33Related).

SIGLECL1 is located on chromosome 19q, a region that clusters other CD33-related siglec genes, suggesting a shared evolutionary pathway and functional similarities among these genes (Crocker2004CD33Related). Although the specific function of SIGLECL1 in healthy human cells is not fully detailed, its involvement in the immune system suggests a role in modulating immune responses and possibly influencing interactions with pathogens. The gene's expression patterns and evolutionary history indicate its importance in maintaining immune homeostasis and responding to environmental challenges (Crocker2004CD33Related).


## References


[1. (Yousef2002Genomic) George M. Yousef, Michael H. Ordon, George Foussias, and Eleftherios P. Diamandis. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes. Gene, 286(2):259–270, March 2002. URL: http://dx.doi.org/10.1016/s0378-1119(02)00432-8, doi:10.1016/s0378-1119(02)00432-8. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0378-1119(02)00432-8)

[2. (Crocker2004CD33Related) Paul R. Crocker. Cd33-related siglecs in the immune system. Trends in Glycoscience and Glycotechnology, 16(91):357–370, 2004. URL: http://dx.doi.org/10.4052/TIGG.16.357, doi:10.4052/tigg.16.357. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.4052/TIGG.16.357)